Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level.
1. In addition to their antihypertensive effect, ACE inhibitors have been reported to increase general well-being, general health and vitality and work performance. The cause of these effects is not known. A possible mechanism may be release of beta-endorphins. 2. In the present study changes in plasma concentration of beta-endorphins on days with ACE inhibitor treatment (n = 12) and on non-treatment control days (n = 12) were compared in 6 patients. 3. Both on control and treatment days the beta-endorphin level fell, by 7.1 and 10.0%, respectively, from 8.00 a.m. to 8.00 p.m., reflecting the known diurnal rhythm of this opioid. This difference between the control and treatment days is not statistically significant. 4. The study should be extended to determine endorphin concentration in the cerebrospinal fluid, and other opioids should be looked for.
Kaada
B
B
Rogaland Central Hospital, Stavanger, Norway.
Woie
L
L
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D002908:Chronic Disease; D004656:Enalapril / Q000031:analogs & derivatives / Q000494:pharmacology; D004723:Endorphins / Q000097:blood*; D005260:Female; D006333:Heart Failure / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D017706:Lisinopril; D008297:Male
D000806:Angiotensin-Converting Enzyme Inhibitors; D004723:Endorphins; D004656:Enalapril; D017706:Lisinopril